Pharmaceutical Stability: Scientific and Regulatory Considerations for Global Drug Development and Commercialization
November 3, 2012
By:
Dilip R. Choudhury
,
Ramesh K. Sood
,
John Bobiak
,
Mark Alasandro
,
Steven W. Baertschi
,
Bekki Komas
,
M. J. Skibic
,
Brian W. Pack
,
Saji Thomas
,
Robert H. Seevers
,
Kim Huynh-Ba
,
Stephen Colgan
,
Robert J. Timpano
,
Ganapathy Mohan
,
David Lin
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
|
AAPS Workshop Summary
November 2, 2012
By:
Dilip R. Choudhury
,
Ramesh K. Sood
,
John Bobiak
,
Mark Alasandro
,
Steven W. Baertschi
,
Bekki Komas
,
M. J. Skibic
,
Brian W. Pack
,
Saji Thomas
,
Robert H. Seevers
,
Kim Huynh-Ba
,
Stephen Colgan
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
|
|
Early Development GMPs for Stability (Part IV)
September 2, 2012
By:
Bruce Acken
,
Mark Alasandro
,
Stephen Colgan
,
Paul Curry
,
Frank Diana
,
Q. Chan Li
,
Z. Jane Li
,
Tony Mazzeo
,
Andy Rignall
,
Z. Jessica Tan
,
Robert Timpano
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.
|
|
